Ghali S, Knox K R, Verbesey J, Scarpidis U, Izadi K, Ganchi P A
Laboratory for Microvascular Research and Vascular Tissue Engineering, New York University, New York, NY, USA.
J Plast Reconstr Aesthet Surg. 2008 Oct;61(10):1226-31. doi: 10.1016/j.bjps.2007.09.011. Epub 2007 Nov 5.
Local anaesthetic agents in combination with epinephrine are frequently used in local reconstructive procedures such as skin tumour excision and local flap closure. The purpose of this study was to measure the effect of subdermal injection of lidocaine combined with epinephrine on cutaneous blood flow in the forearm and in the face.
Thirty injections were performed on the forearm and 40 injections were performed on the face in five healthy volunteers. In both anatomical regions, 0.9% phosphate buffered saline (PBS) was used as a control, and experimental injections included 1% lidocaine either alone or in combination with 1:100,000 epinephrine, and an additional combination of 1% lidocaine with 1:200,000 epinephrine used in the facial experiments. Cutaneous blood flow was measured indirectly using laser Doppler imaging (moorLDI-Mark 2).
A statistically significant increase in blood flow was achieved with injection of lidocaine in the forearm compared to saline, whereas a non-statistically significant increase was achieved with saline injection compared to lidocaine in the face. This occurred in the first 5 min in the forearm and 2 min in the face. The addition of 1:100,000 epinephrine to lidocaine resulted in an immediate decrease in cutaneous blood flow which was maximal at 10 min in the forearm and 8 min in the face. This was statistically significant compared to all other injections except for the combination of 1:200,000 epinephrine with lidocaine, injected in the face.
The vascularity of different anatomical areas may account for blood flow differences following injection with saline and lidocaine. Incisions should be delayed for 10 min in the forearm and 8 min in the face following lidocaine+epinephrine injection to allow maximal benefit to take effect. There were no significant differences between 1:100,000 and 1:200,000 epinephrine combined with lidocaine in facial injections his study.
局部麻醉剂与肾上腺素联合常用于局部重建手术,如皮肤肿瘤切除和局部皮瓣闭合。本研究的目的是测量皮下注射利多卡因联合肾上腺素对前臂和面部皮肤血流的影响。
对5名健康志愿者在前臂进行了30次注射,在面部进行了40次注射。在两个解剖区域,均使用0.9%磷酸盐缓冲盐水(PBS)作为对照,实验注射包括单独使用1%利多卡因或与1:100,000肾上腺素联合使用,以及在面部实验中使用的1%利多卡因与1:200,000肾上腺素的额外组合。使用激光多普勒成像(moorLDI-Mark 2)间接测量皮肤血流。
与盐水相比,前臂注射利多卡因后血流有统计学意义的增加,而面部注射盐水与利多卡因相比血流增加无统计学意义。这在前臂的前5分钟和面部的前2分钟出现。利多卡因中加入1:100,000肾上腺素导致皮肤血流立即减少,在前臂10分钟时和面部8分钟时达到最大。与除面部注射的1:200,000肾上腺素与利多卡因组合外的所有其他注射相比,这具有统计学意义。
不同解剖区域的血管分布可能是注射盐水和利多卡因后血流差异的原因。利多卡因+肾上腺素注射后,前臂切口应延迟10分钟,面部切口应延迟8分钟,以使最大益处生效。本研究中,面部注射中1:100,000和1:200,000肾上腺素与利多卡因联合使用之间无显著差异。